Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression

Recruiting

Phase 2

PsilocybinAcceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression

Sponsor:

The University of Texas Health Science Center, Houston

Code:

NCT06706232

Conditions

Bipolar II Disorder

Depression, Bipolar

Suicidality

Eligibility Criteria

Sex: All

Age: 25 - 70

Healthy Volunteers: Not accepted

Interventions

Psilocybin

Therapeutic Support

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-19. This information was provided to ClinicalTrials.gov by The University of Texas Health Science Center, Houston on 2025-03-13.